Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Ganga Pharma.
|
Ortin Global
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.9 % | 1.2 % | -57.26 % |
|
5yr average Equity Multiplier
|
1.02 | 1.4 | 2.67 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.33 | 0.6 |
|
5yr Avg Net Profit Margin
|
0.0 | 2.35 % | -75.26 % |
|
Price to Book
|
5.61 | 0.0 | 5.06 |
|
P/E
|
0.0 | 110.65 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 183.46 Days | 597.13 Days |
|
Inventory Days
|
0.0 | 158.14 Days | 335.19 Days |
|
Days Receivable
|
0.0 | 120.91 Days | 448.05 Days |
|
Days Payable
|
68.55 Days | 141.14 Days | 649.97 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 1.42 | -2.05 |
|
5yr Avg ROCE
|
-8.89 % | 4.7 % | -24.19 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 3.58 % | -55.65 % |
|
5 yr average Debt to Equity
|
0.0 | 0.3 | 0.64 |
|
5yr CAGR Net Profit
|
-28.89 % | -23.43 % | 44.41 % |
|
5yr Average Return on Assets
|
-8.72 % | 0.85 % | -20.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.98 % | 50.91 % | 1.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -15.8 % | -14.45 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Ganga Pharma.
|
Ortin Global
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|